Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Volavka

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|November 29, 2002
Ladislav Haskovec and akathisia: 100th anniversaryPavel Mohr, Jan Volavka
The American Journal of Psychiatry|September 4, 2018
Understanding the Risk of Treatment Failure After Discontinuation of Long-Term Antipsychotic TreatmentPál Czobor, Jan Volavka
Schizophrenia Bulletin|May 13, 2011
Pathways to aggression in schizophrenia affect results of treatmentJan Volavka, Leslie Citrome
Postgraduate Medicine|October 30, 2004
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioningLeslie Citrome, Jan Volavka
JAMA|March 5, 2004
Olanzapine vs haloperidol for treatment of schizophreniaJan Volavka, Leslie Citrome
Expert Opinion on Pharmacotherapy|June 30, 2009
Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-makingJan Volavka, Leslie Citrome
Journal of Psychiatric Practice|January 25, 2006
Video recording in the assessment of violent incidents in psychiatric hospitalsKarea A Nolan, Jan Volavka
The Psychiatric Quarterly|July 16, 2008
Methodological structure for aggression researchJan Volavka, Karen A Nolan
Annals of the New York Academy of Sciences|April 9, 2005
Catecholamines and aggression: the role of COMT and MAO polymorphismsJan Volavka, Robert Bilder, Karen Nolan
CNS Spectrums|February 10, 2017
Measurement of agitation and aggression in adult and aged neuropsychiatric patients: review of definitions and frequently used measurement scalesLadislav Volicer, Leslie Citrome, Jan Volavka
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
The British Journal of Psychiatry : the Journal of Mental Science|November 29, 2002
Ladislav Haskovec and akathisia: 100th anniversaryPavel Mohr, Jan Volavka
The American Journal of Psychiatry|September 4, 2018
Understanding the Risk of Treatment Failure After Discontinuation of Long-Term Antipsychotic TreatmentPál Czobor, Jan Volavka
Schizophrenia Bulletin|May 13, 2011
Pathways to aggression in schizophrenia affect results of treatmentJan Volavka, Leslie Citrome
Postgraduate Medicine|October 30, 2004
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioningLeslie Citrome, Jan Volavka
JAMA|March 5, 2004
Olanzapine vs haloperidol for treatment of schizophreniaJan Volavka, Leslie Citrome
Expert Opinion on Pharmacotherapy|June 30, 2009
Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-makingJan Volavka, Leslie Citrome
Journal of Psychiatric Practice|January 25, 2006
Video recording in the assessment of violent incidents in psychiatric hospitalsKarea A Nolan, Jan Volavka
The Psychiatric Quarterly|July 16, 2008
Methodological structure for aggression researchJan Volavka, Karen A Nolan
Annals of the New York Academy of Sciences|April 9, 2005
Catecholamines and aggression: the role of COMT and MAO polymorphismsJan Volavka, Robert Bilder, Karen Nolan
CNS Spectrums|February 10, 2017
Measurement of agitation and aggression in adult and aged neuropsychiatric patients: review of definitions and frequently used measurement scalesLadislav Volicer, Leslie Citrome, Jan Volavka
Pageof 10